Financial results: Bod Science; Zelira Therapeutics; Emyria; Epsilon Healthcare; Elixinol; MGC Pharma by Steve Jones August 1, 2023April 30, 2024 Bod Science is plotting a capital raise and investigating new revenue streams as it reassured the […]
Study delivers ‘new chapter’ for Bod as Aqua Phase tech shows its worth by Steve Jones July 26, 2023April 30, 2024
Bod plotting ‘immediate’ overseas move if CBD sleep trial succeeds by Steve Jones July 19, 2023April 30, 2024
Bod Science faces nervy wait as final patient completes S3 clinical trial by Steve Jones July 10, 2023April 30, 2024
Bod Science to test drug-delivery tech on psychiatric medication by Steve Jones May 31, 2023April 30, 2024
Hopes rising at Bod Science over commercial prospects for Aqua Phase by Steve Jones May 23, 2023April 30, 2024
Bod medical sales fall as demand continues for high-THC products by Steve Jones May 1, 2023April 30, 2024
Company news: Cann Global; Elixinol; Bod Science; AusCann; IvyMed Clinic; Botanix by Steve Jones and Martin Lane April 5, 2023April 30, 2024
Bod Science submits ethics approval for bioavailability study by Steve Jones March 28, 2023April 30, 2024